Jose Pedro A, Soares-da-Silva Patricio, Eisner Gilbert M, Felder Robin A
Children's National Medical Center, George Washington University for the Health Sciences, Washington, DC, USA.
Biochim Biophys Acta. 2010 Dec;1802(12):1259-67. doi: 10.1016/j.bbadis.2010.02.004. Epub 2010 Feb 12.
Complex interactions between genes and environment result in a sodium-induced elevation in blood pressure (salt sensitivity) and/or hypertension that lead to significant morbidity and mortality affecting up to 25% of the middle-aged adult population worldwide. Determining the etiology of genetic and/or environmentally-induced high blood pressure has been difficult because of the many interacting systems involved. Two main pathways have been implicated as principal determinants of blood pressure since they are located in the kidney (the key organ responsible for blood pressure regulation), and have profound effects on sodium balance: the dopaminergic and renin-angiotensin systems. These systems counteract or modulate each other, in concert with a host of intracellular second messenger pathways to regulate sodium and water balance. In particular, the G protein-coupled receptor kinase type 4 (GRK4) appears to play a key role in regulating dopaminergic-mediated natriuresis. Constitutively activated GRK4 gene variants (R65L, A142V, and A486V), by themselves or by their interaction with other genes involved in blood pressure regulation, are associated with essential hypertension and/or salt-sensitive hypertension in several ethnic groups. GRK4γ 142Vtransgenic mice are hypertensive on normal salt intake while GRK4γ 486V transgenic mice develop hypertension only with an increase in salt intake. GRK4 gene variants have been shown to hyperphosphorylate, desensitize, and internalize two members of the dopamine receptor family, the D(1) (D(1)R) and D(3) (D(3)R) dopamine receptors, but also increase the expression of a key receptor of the renin-angiotensin system, the angiotensin type 1 receptor (AT(1)R). Knowledge of the numerous blood pressure regulatory pathways involving angiotensin and dopamine may provide new therapeutic approaches to the pharmacological regulation of sodium excretion and ultimately blood pressure control.
基因与环境之间的复杂相互作用导致钠诱导的血压升高(盐敏感性)和/或高血压,进而引发严重的发病率和死亡率,影响着全球多达25%的中年成年人。由于涉及众多相互作用的系统,确定遗传和/或环境诱导的高血压病因一直很困难。两条主要途径被认为是血压的主要决定因素,因为它们位于肾脏(负责血压调节的关键器官),并对钠平衡有深远影响:多巴胺能系统和肾素-血管紧张素系统。这些系统相互抵消或调节,与许多细胞内第二信使途径协同作用以调节钠和水平衡。特别是,G蛋白偶联受体激酶4型(GRK4)似乎在调节多巴胺能介导的利钠作用中起关键作用。组成型激活的GRK4基因变体(R65L、A142V和A486V),单独或通过与其他参与血压调节的基因相互作用,与几个种族的原发性高血压和/或盐敏感性高血压相关。GRK4γ 142V转基因小鼠在正常盐摄入时会出现高血压,而GRK4γ 486V转基因小鼠仅在盐摄入量增加时才会出现高血压。已表明GRK4基因变体可使多巴胺受体家族的两个成员D(1)(D(1)R)和D(3)(D(3)R)多巴胺受体过度磷酸化、脱敏并使其内化,但也会增加肾素-血管紧张素系统的关键受体血管紧张素1型受体(AT(1)R)的表达。了解涉及血管紧张素和多巴胺的众多血压调节途径可能为钠排泄的药理调节以及最终的血压控制提供新的治疗方法。